Calibration test of PET scanners in a multi-centre clinical trial on breast cancer therapy monitoring using 18F-FLT.

Calibration test of PET scanners in a multi-centre clinical trial on breast cancer therapy monitoring using 18F-FLT.

A multi-centre trial using PET requires the analysis of images acquired on different systems We designed a multi-centre trial to estimate the value of 18F-FLT-PET to predict response to neoadjuvant chemotherapy in patients with newly diagnosed breast cancer. A calibration check of each PET-CT and of...

Full description

Bibliographic Details
Main Authors:	Francis Bouchet, Lilli Geworski, Bernd O Knoop, Ludovic Ferrer, Alina Barriolo-Riedinger, Corinne Millardet, Marjolaine Fourcade, Antoine Martineau, Anne Belly-Poinsignon, Francis Djoumessi, Karine Tendero, Laurent Keros, Frederic Montoya, Christel Mesleard, Anne-Laure Martin, Franck Lacoeuille, Olivier Couturier
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3596383?pdf=render

Similar Items

Dual time point [18F]FLT-PET for differentiating proliferating tissues vs non-proliferating tissues
by: Pierre Lovinfosse, et al.
Published: (2019-12-01)

Voraussetzungen für die Quantifizierung in der Emissions-Tomographie
by: Geworski, Lilli
Published: (2004)

The Myc/Max/Mxd Network Is a Target of Mutated Flt3 Signaling in Hematopoietic Stem Cells in Flt3-ITD-Induced Myeloproliferative Disease
by: Farhan Basit, et al.
Published: (2018-01-01)

OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia
by: Bartholomew J. Eisfelder, et al.
Published: (2021-03-01)

Polymorphisms in the Flt1 gene and their relation to expression of the secreted Flt1 variant
by: Ajlouni, Burouj Kayed
Published: (2014)

CCL5 mediates target‐kinase independent resistance to FLT3 inhibitors in FLT3‐ITD‐positive AML
by: Silvia Waldeck, et al.
Published: (2020-04-01)

The Flt3L/Flt3 Axis in Dendritic Cell Biology and Cancer Immunotherapy
by: Francisco J. Cueto, et al.
Published: (2021-03-01)

Dendritic poly(3-hexylthiophene) star copolymer systems for next generation bulk heterojunction organic photovoltaic cells
by: Yonkeu, Anne Lutgarde Djoumessi
Published: (2019)

Unlocking the potential of translation for FLT
by: Alenka Kocbek
Published: (2014-12-01)

Inhibition of FLT3 expression by green tea catechins in FLT3 mutated-AML cells.
by: Bui Thi Kim Ly, et al.
Published: (2013-01-01)

Overcoming Resistance to FLT3 Inhibitors in the Treatment of <i>FLT3</i>-Mutated AML
by: Stephen S.Y. Lam, et al.
Published: (2020-02-01)

Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia
by: Abhishek Maiti, et al.
Published: (2021-02-01)

Comparison of FLT3 inhibitors with the standard treatment for FLT3-ITD mutated acute myeloid leukemia
by: Argetsinger, Stephanie
Published: (2019)

Role of RNA Processing Factors in the Expression of Flt-1 and its Secreted Variant, sFlt-1
by: Roche, Rebecca I.
Published: (2014)

Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
by: Chen, Y., et al.
Published: (2022)

Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth.
by: Mark C Weir, et al.
Published: (2017-01-01)

Reversible resistance induced by FLT3 inhibition: a novel resistance mechanism in mutant FLT3-expressing cells.
by: Ellen Weisberg, et al.
Published: (2011-01-01)

Flt3/Flt3L Participates in the Process of Regulating Dendritic Cells and Regulatory T Cells in DSS-Induced Colitis
by: Jing-Wei Mao, et al.
Published: (2014-01-01)

Survey of activated FLT3 signaling in leukemia.
by: Ting-lei Gu, et al.
Published: (2011-04-01)

The biology and targeting of FLT3 in pediatric leukemia
by: Colleen eAnnesley, et al.
Published: (2014-09-01)

FLT3 inhibitors in acute myeloid leukemia
by: Mei Wu, et al.
Published: (2018-12-01)

FLT3 inhibitors in acute myeloid leukaemia
by: Knapper, Steven
Published: (2005)

Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia.
by: Adrián Mosquera Orgueira, et al.
Published: (2021-01-01)

Production of an anti-angiogenic factor sFLT1 is suppressed via promoter hypermethylation of FLT1 gene in choriocarcinoma cells
by: Tadashi Sasagawa, et al.
Published: (2020-02-01)

sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics
by: Viktorija Tarasevičienė, et al.
Published: (2016-01-01)

mTOR signaling is activated by FLT3 kinase and promotes survival of <it>FLT3-</it>mutated acute myeloid leukemia cells
by: Panayiotidis Panayiotis, et al.
Published: (2010-11-01)

FLT3 Tyrosine Kinase Inhibitors for the Treatment of Fit and Unfit Patients with FLT3-Mutated AML: A Systematic Review
by: Michael Loschi, et al.
Published: (2021-05-01)

FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET
by: Patrick Martineau, et al.
Published: (2020-12-01)

FLT3 internal tandem duplication and FLT3-D835 mutation in 80 AML patients categorized into cytogenetic risk groups
by: Ewa Mały DEF, et al.
Published: (2010-10-01)

CXCR4 Inhibition Enhances Efficacy of FLT3 Inhibitors in FLT3-Mutated AML Augmented by Suppressed TGF-b Signaling
by: Bo-Reum Kim, et al.
Published: (2020-06-01)

Enhancement of mucosal enterovirus vaccine immune response with Flt3L protein or Flt3L-VP1 fusion gene.
by: Szu-Wei Lin, et al.
Published: (2007)

Zusammenhang zwischen angiogenen Faktoren (sFlt-1/PlGF-Ratio) und klinischen Parametern des Schwangerschaftsausgangs bei manifesten hypertensiven Schwangerschaftserkrankungen
by: Tauscher, Anne
Published: (2013)

Novel Approaches to Target Mutant FLT3 Leukaemia
by: Jörg P. Müller, et al.
Published: (2020-09-01)

FLT3 mutations in canine acute lymphocytic leukemia
by: Seiser Eric L, et al.
Published: (2011-01-01)

Targeting FLT3 Mutations in Acute Myeloid Leukemia
by: Riad El Fakih, et al.
Published: (2018-01-01)

Culture Issues in FLT Towards the Fostering of Intercultural Awareness
by: Souryana Yassine
Published: (2006-06-01)

Abundance of Flt3 and its ligand in astrocytic tumors
by: E&szlig;bach C, et al.
Published: (2013-05-01)

FLT3-ITD Incidence and FLT-D835 Mutations in Acute Myeloid Leukemia Patients with Normal Karyotype in Morocco: A Preliminary Study
by: Hind Dehbi, et al.
Published: (2013-01-01)

Theoretical Studies Aimed at Finding FLT3 Inhibitors and a Promising Compound and Molecular Pattern with Dual Aurora B/FLT3 Activity
by: Ítalo Antônio Fernandes, et al.
Published: (2020-04-01)

Computer simulations of the signalling network in FLT3 +-acute myeloid leukaemia – indications for an optimal dosage of inhibitors against FLT3 and CDK6
by: Antoine Buetti-Dinh, et al.
Published: (2018-04-01)